Healthcare technology company GE HealthCare Technologies (NASDAQ: GEHC) will be reporting earnings tomorrow before market hours. Here’s what to expect.
GE HealthCare met analysts’ revenue expectations last quarter, reporting revenues of $5.32 billion, up 2.2% year on year. It was a satisfactory quarter for the company, with a solid beat of analysts’ EPS estimates.
Is GE HealthCare a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting GE HealthCare’s revenue to be flat year on year at $4.66 billion, improving from the 1.2% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.91 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. GE HealthCare has missed Wall Street’s revenue estimates six times over the last two years.
Looking at GE HealthCare’s peers in the healthcare equipment and supplies segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Penumbra delivered year-on-year revenue growth of 16.3%, beating analysts’ expectations by 2.7%, and Boston Scientific reported revenues up 20.9%, topping estimates by 2%. Penumbra traded up 7.2% following the results while Boston Scientific was also up 6.5%.
Read our full analysis of Penumbra’s results here and Boston Scientific’s results here.
Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the healthcare equipment and supplies stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 5.2% on average over the last month. GE HealthCare is down 15.6% during the same time and is heading into earnings with an average analyst price target of $97.01 (compared to the current share price of $68.14).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
